Bixiye
QP33-25 Commercial Pharmacy Benefit Exclusion for Bkemv™, Otulfi™, Pyzchiva®, Selarsdi™ and Ustekinumab-ttwe™
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Natiijooyinka Raadinta
Soo bandhiga 2881 - 2890 ee natiijooyinka 4296
Bixiye
QP32-25 Cotiviti to Begin Preventable Readmission Audits
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Bixiye
QP31-25 Peer-to-Peer Discussions for Denied Claims Ending
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Bixiye
2025 May Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
P30-25 Prime Therapeutics Management (UM) Program: Medical Drug Updates
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025